Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma [Phase 1, Phase 2]
Clinical trial update for BNC105P combined with everolimus in progressive metastatic clear cell renal cell carcinoma; phases 1 and 2 complet…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 study investigating high-dose aldesleukin (interleukin-2) for metastatic renal cell carcinoma has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate [Phase 1, Phase 2]
Phase 1/2 trial investigating panobinostat and everolimus in metastatic or unresectable renal cell cancer after failure of sunitinib or sora…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Neoadjuvant Pazopanib in Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating neoadjuvant pazopanib for renal cell carcinoma has completed, with results posted on May 10, 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating the combination of everolimus and low-dose cyclophosphamide in patients with metastatic renal cell ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients [Phase 2]
This document reports on a Phase 2 clinical trial evaluating the combination of bevacizumab and sorafenib as third-line therapy for metastat…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial [NA]
This entry notes a completed randomized trial comparing Dual Energy CT to Standard Triple Phase CT Angiography. The study involved patients …
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method [Phase 4]
A Phase 4 trial assessing how different anesthesia methods influence cardiac arrhythmias in patients undergoing renal cell carcinoma surgery…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II) [Phase 3]
This entry documents the completed Phase III SWITCH-II trial, which compared sequences of sorafenib followed by pazopanib versus pazopanib f…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma [Phase 2]
Phase 2 trial update for NEXT exploring subsequent exposure to tyrosine kinase inhibition at recurrence after adjuvant therapy in renal cell…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer [EARLY_Phase 1]
This clinical trial update reports an early-phase 1 study of sorafenib in patients undergoing surgery for stage II–IV kidney cancer, and the…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma [NA]
A terminated clinical trial at Indiana University studied PET/CT assessment of tumor perfusion in renal cell carcinoma; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase II trial evaluating sunitinib rechallenge in metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell Carcinoma [NA]
Completed clinical trial comparing microwave ablation-assisted enucleation versus conventional laparoscopic partial nephrectomy for T1a rena…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]
Phase 2 trial update reporting results for ziv-aflibercept in patients with metastatic or unresectable kidney cancer; results were posted in…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Nexavar Dosing in Renal Cancer Patients in "Real-life" Setting
This completed trial update describes how Nexavar (sorafenib) was dosed in renal cell carcinoma patients in real-world clinical settings.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer [Phase 1, Phase 2]
A dose-escalation Phase I/II trial evaluating Lutetium-177-labeled cG250 for advanced/metastatic renal cell carcinoma has completed enrollme…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: CyberKnife for Unresectable Renal Tumors [NA]
A completed clinical trial evaluating CyberKnife radiosurgery for unresectable renal tumors (kidney cancer).
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: A Study of RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy [Phase 2]
Phase 2 trial evaluating RO4929097 in patients with advanced renal cell carcinoma after VEGF/VEGFR therapy has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma [Phase 2]
Phase II trial evaluating gemcitabine in combination with Doxil for metastatic renal cell carcinoma has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers [Phase 1]
Phase 1 study assessing the combination of panobinostat with sorafenib in renal cell carcinoma, soft tissue sarcoma, and non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients [Phase 2]
A Phase 2 study evaluating recombinant human interleukin-21 in combination with sunitinib for stage IV renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating the combination of bevacizumab and temsirolimus for advanced renal cell carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer [Phase 2]
Phase 2 trial of pharmacokinetically guided everolimus in patients with breast cancer, pancreatic neuroendocrine tumors, or renal cell carci…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect. [Phase 1, Phase 2]
A Phase I/II trial evaluated stereotactic body radiotherapy with concurrent fixed-dose tyrosine kinase inhibitors in metastatic renal cell c…